HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review)
Oncology Reports · 01.04.2026 · 55 (6) · 1-12
DOI: 10.3892/or.2026.9109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 01.04.2026. Verfasst von Ju Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214002, P.R. China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, HMGB3 Protein, Neoplastic Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214002, P.R. China.
- Department of Urology, Jiangnan University Medical Center, Wuxi, Jiangsu 214002, P.R. China.
- Department of Neurology, Jiangnan University Medical Center, Wuxi, Jiangsu 214002, P.R. China.
Zitieren
APA
Zhang, J., Sun, Y., Wang, L., Gu, J., Hua, Y., Shao, J., & Feng, N. (2026). HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review). Oncology Reports, 55(6), 1-12. https://doi.org/10.3892/or.2026.9109
Vancouver
Zhang J, Sun Y, Wang L, Gu J, Hua Y, Shao J, et al. HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review). Oncology Reports. 2026;55(6):1-12. doi:10.3892/or.2026.9109
BibTeX
@article{Zhang2026,
author = {Zhang, Ju and Sun, Yifan and Wang, Lanyu and Gu, Jiayu and Hua, Ye and Shao, Jianfeng and Feng, Ninghan},
title = {HMGB3: A pivotal orchestrator of therapy resistance and cancer stemness in human malignancies (Review)},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {6},
pages = {1--12},
doi = {10.3892/or.2026.9109}
}
EUVIMED